Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 14, 2015; 21(46): 13073-13079
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13073
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13073
Table 2 Antimicrobial susceptibility testing in Helicobacter pylori strains n (%)
| Antibiotic | Resistant isolates of each group in follow-up patients | |||
| Total (n = 920) | A group (n = 366) | B group (n = 346) | C group (n = 208) | |
| CLR | 82 (8.91) | 29 (7.9) | 30 (8.67) | 23 (11.06) |
| LVX | 136 (14.78) | 54 (14.75) | 50 (14.45) | 32 (15.38) |
| MTZ | 881 (95.76) | 354 (96.72) | 330 (95.38) | 197 (94.71) |
| MTZ + CLR | 79 (8.59) | 28 (7.65) | 29 (8.38) | 22 (10.58) |
| MTZ + LVX | 131 (14.24) | 52 (14.21) | 49 (14.16) | 30 (14.42) |
| CLR + LVX | 39 (4.24) | 9 (2.50) | 13 (3.76) | 17 (8.17) |
| MTZ + CLR + LVX | 37 (4.02) | 9 (2.50) | 12 (3.47) | 16 (7.69) |
-
Citation: Tong YF, Lv J, Ying LY, Xu F, Qin B, Chen MT, Meng F, Tu MY, Yang NM, Li YM, Zhang JZ. Seven-day triple therapy is a better choice for
Helicobacter pylori eradication in regions with low antibiotic resistance. World J Gastroenterol 2015; 21(46): 13073-13079 - URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13073.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i46.13073